SEC Form 4 · accession 0001615774-17-000040
Enumeral Biomedical Holdings, Inc. · ENUM
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Robert J Easton
Director
Period of report
Jan 3, 2017
Accepted (ET)
Jan 5, 2017 · 4:17 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001561551
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock Option (Right to Buy)F1 | $0.15 | Jan 3, 2017 | A | 233,333 | A | — | Jan 2, 2027 | Common Stock | 233,333 | 233,333 | D |
Explanation of responses
- F1Represents a stock option award granted by Enumeral Biomedical Holdings, Inc. (the "Company") pursuant to its non-employee director compensation program and the Company's 2014 Equity Incentive Plan, as amended. The option vests and becomes exercisable in 4 quarterly installments on each of January 3, 2017, April 1, 2017, July 1, 2017, and October 1, 2017.